To examine whether CD276-CAR NK-92 cells can also successfully target melanoma, commercially available melanoma cell lines, among others FM-3, Mel-Juso and WM115, were screened for their CD276 surface expression using flow cytometry (Figure 1). Here, CD276 is linked to melanoma.